Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Malignant Lymphoma

  Free Subscription


5 Blood
1 Br J Dermatol
1 Br J Haematol
2 Cancer
2 Cancer Res
1 Eur J Haematol
1 Haematologica
1 Hum Pathol
2 Int J Radiat Oncol Biol Phys
1 J Am Acad Dermatol
2 Leuk Lymphoma
1 Leukemia
1 N Engl J Med
3 Oncogene
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. MALT lymphoma prognostic index.
    Blood. 2017;130:1486.
    PubMed     Text format    

  2. ZHENG L, Hu S
    Philadelphia chromosome-positive B-lymphoblastic lymphoma involving the genitourinary system and bone at initial diagnosis and relapse.
    Blood. 2017;130:1483.
    PubMed     Text format    

    Targeting BCL-2 in B-cell lymphomas.
    Blood. 2017;130:1081-1088.
    PubMed     Text format     Abstract available

  4. PARK J, Yang J, Wenzel AT, Ramachandran A, et al
    Genomic analysis of 220 CTCLs identifies a novel recurrent gain-of-function alteration in RLTPR (p.Q575E).
    Blood. 2017;130:1430-1440.
    PubMed     Text format     Abstract available

  5. KREMER KN, Dinkel BA, Sterner RM, Osborne DG, et al
    TCR-CXCR4 signaling stabilizes cytokine mRNA transcripts via a PREX1-Rac1 pathway: implications for CTCL.
    Blood. 2017;130:982-994.
    PubMed     Text format     Abstract available

    Br J Dermatol

  6. LIAW TY, Liang CW
    Image Gallery: Generalized annular figurate erythema as an unusual presentation of angioimmunoblastic T-cell lymphoma.
    Br J Dermatol. 2017;177:e75.
    PubMed     Text format    

    Br J Haematol

  7. THANARAJASINGAM G, Maurer MJ, Farooq U, Johnston PB, et al
    Event-free survival at 24 months captures central nervous system relapse of systemic diffuse large B-cell lymphoma in the immunochemotherapy era.
    Br J Haematol. 2017 Sep 29. doi: 10.1111/bjh.14922.
    PubMed     Text format    


  8. HAN CH, Batchelor TT
    Diagnosis and management of primary central nervous system lymphoma.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.30965.
    PubMed     Text format     Abstract available

  9. MAJZNER RG, Simon JS, Grosso JF, Martinez D, et al
    Assessment of programmed death-ligand 1 expression and tumor-associated immune cells in pediatric cancer tissues.
    Cancer. 2017;123:3807-3815.
    PubMed     Text format     Abstract available

    Cancer Res

  10. FEELEY KP, Adams CM, Mitra R, Eischen CM, et al
    Mdm2 Is Required for Survival and Growth of p53-Deficient Cancer Cells.
    Cancer Res. 2017;77:3823-3833.
    PubMed     Text format     Abstract available

  11. O'STEEN S, Green DJ, Gopal AK, Orozco JJ, et al
    Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas.
    Cancer Res. 2017;77:3885-3893.
    PubMed     Text format     Abstract available

    Eur J Haematol

  12. BROCKELMANN PJ, Zagadailov EA, Corman SL, Chirikov V, et al
    Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma who are Ineligible for Autologous Stem Cell Transplant: A Germany and UK Retrospective Study.
    Eur J Haematol. 2017 Sep 26. doi: 10.1111/ejh.12973.
    PubMed     Text format     Abstract available


  13. LUGTENBURG P, Avivi I, Berenschot H, Ilhan O, et al
    Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study.
    Haematologica. 2017 Sep 21. pii: haematol.2017.173583.
    PubMed     Text format     Abstract available

    Hum Pathol

  14. MAESHIMA AM, Taniguchi H, Suzuki T, Yuda S, et al
    Comparison of clinicopathologic characteristics of gastric follicular lymphomas and duodenal follicular lymphomas.
    Hum Pathol. 2017;65:201-208.
    PubMed     Text format     Abstract available

    Int J Radiat Oncol Biol Phys

  15. MELCHERS RC, Willemze R, Daniels LA, Neelis KJ, et al
    Recommendations for the Optimal Radiation Dose in Patients With Primary Cutaneous Anaplastic Large Cell Lymphoma: A Report of the Dutch Cutaneous Lymphoma Group.
    Int J Radiat Oncol Biol Phys. 2017 Aug 24. pii: S0360-3016(17)33721.
    PubMed     Text format     Abstract available

  16. TSENG YD, Cutter DJ, Plastaras JP, Parikh RR, et al
    Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee.
    Int J Radiat Oncol Biol Phys. 2017 Sep 21. pii: S0360-3016(17)30901.
    PubMed     Text format    

    J Am Acad Dermatol

  17. MANGOLD AR, Thompson AK, Davis MD, Saulite I, et al
    Early clinical manifestations of Sezary syndrome: A multicenter retrospective cohort study.
    J Am Acad Dermatol. 2017;77:719-727.
    PubMed     Text format     Abstract available

    Leuk Lymphoma

  18. XU ZZ, Shen JK, Zhao SQ, Li JM, et al
    Clinical significance of chemokine receptor CXCR4 and mammalian target of rapamycin (mTOR) expression in patients with diffuse large B-cell lymphoma.
    Leuk Lymphoma. 2017 Sep 27:1-10. doi: 10.1080/10428194.2017.1379077.
    PubMed     Text format     Abstract available

  19. KAMRAN SC, Jacene HA, Chen YH, Mauch PM, et al
    Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD x two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.
    Leuk Lymphoma. 2017 Sep 22:1-7. doi: 10.1080/10428194.2017.1376745.
    PubMed     Text format     Abstract available


  20. RUELLA M, Kenderian SS, Shestova O, Klichinsky M, et al
    Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms.
    Leukemia. 2017;31:246-248.
    PubMed     Text format    

    N Engl J Med

  21. LE GOUILL S, Thieblemont C, Oberic L, Moreau A, et al
    Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.
    N Engl J Med. 2017;377:1250-1260.
    PubMed     Text format     Abstract available


  22. MOYO TK, Wilson CS, Moore DJ, Eischen CM, et al
    Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition.
    Oncogene. 2017;36:4653-4661.
    PubMed     Text format     Abstract available

  23. GUO X, Koff JL, Moffitt AB, Cinar M, et al
    Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
    Oncogene. 2017;36:4224-4232.
    PubMed     Text format     Abstract available

  24. TONELLI C, Morelli MJ, Sabo A, Verrecchia A, et al
    Genome-wide analysis of p53-regulated transcription in Myc-driven lymphomas.
    Oncogene. 2017;36:2921-2929.
    PubMed     Text format     Abstract available

    PLoS One

  25. ISAEVSKA E, Manasievska M, Alessi D, Mosso ML, et al
    Cancer incidence rates and trends among children and adolescents in Piedmont, 1967-2011.
    PLoS One. 2017;12:e0181805.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.